Eyenovia, Inc. - Special Call Transcript
Greetings and welcome to Eyenovia Corporate Update Conference Call. (Operator Instructions) Please note, this conference is being recorded.
I would now like to turn the conference over to your host, Eric Ribner, Investor Relations. Thank you. You may begin.
Good afternoon and welcome to Eyenovia's conference call to discuss the company's exclusive license agreement with Bausch + Lomb, and both companies -- that both companies announced yesterday, along with Eyenovia's other recent business development activities.
With me today are Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer; Michael Rowe, Eyenovia's Vice President of Commercial; and John Gandolfo, Eyenovia's Chief Financial Officer.
Except for historical information, all of the statements, expectations and assumptions contained in this conference call are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |